{"name":"Labopharm Inc.","slug":"labopharm-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"Zaldiar®","genericName":"Zaldiar®","slug":"zaldiar","indication":"Moderate acute pain","status":"marketed"},{"name":"Tramadol HCl Contramid® Once A Day","genericName":"Tramadol HCl Contramid® Once A Day","slug":"tramadol-hcl-contramid-once-a-day","indication":"Moderate to moderately severe pain","status":"phase_3"},{"name":"Tramadol HCl","genericName":"Tramadol HCl","slug":"tramadol-hcl","indication":"Moderate pain in adults","status":"marketed"},{"name":"Tramadol HCl Twice a day","genericName":"Tramadol HCl Twice a day","slug":"tramadol-hcl-twice-a-day","indication":"Moderate to moderately severe pain","status":"phase_3"},{"name":"Tramadol OAD","genericName":"Tramadol OAD","slug":"tramadol-oad","indication":"Moderate to moderately severe chronic pain","status":"phase_3"},{"name":"Tramadol Once A Day","genericName":"Tramadol Once A Day","slug":"tramadol-once-a-day","indication":"Moderate to moderately severe pain","status":"phase_3"},{"name":"Ultracet®","genericName":"Ultracet®","slug":"ultracet","indication":"Moderate acute pain in adults","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Trazodone HCl","genericName":"Trazodone HCl","slug":"trazodone-hcl","indication":"Major depressive disorder","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Zytram","genericName":"Zytram","slug":"zytram","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Zaldiar®","genericName":"Zaldiar®","slug":"zaldiar","phase":"marketed","mechanism":"Zaldiar combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with paracetamol (acetaminophen) to provide analgesia through dual pathways.","indications":["Moderate acute pain","Moderate chronic pain"],"catalyst":""},{"name":"Tramadol HCl Contramid® Once A Day","genericName":"Tramadol HCl Contramid® Once A Day","slug":"tramadol-hcl-contramid-once-a-day","phase":"phase_3","mechanism":"Tramadol HCl is a centrally acting opioid analgesic that works by binding to mu-opioid receptors in the brain.","indications":["Moderate to moderately severe pain","Severe pain"],"catalyst":""},{"name":"Tramadol HCl","genericName":"Tramadol HCl","slug":"tramadol-hcl","phase":"marketed","mechanism":"Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.","indications":["Moderate pain in adults","Moderate to moderately severe pain"],"catalyst":""},{"name":"Tramadol HCl Twice a day","genericName":"Tramadol HCl Twice a day","slug":"tramadol-hcl-twice-a-day","phase":"phase_3","mechanism":"Tramadol HCl is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord, reducing pain perception.","indications":["Moderate to moderately severe pain","Severe pain"],"catalyst":""},{"name":"Tramadol OAD","genericName":"Tramadol OAD","slug":"tramadol-oad","phase":"phase_3","mechanism":"Tramadol is an opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.","indications":["Moderate to moderately severe chronic pain"],"catalyst":""},{"name":"Tramadol Once A Day","genericName":"Tramadol Once A Day","slug":"tramadol-once-a-day","phase":"phase_3","mechanism":"Tramadol is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord.","indications":["Moderate to moderately severe pain","Severe pain"],"catalyst":""},{"name":"Trazodone HCl","genericName":"Trazodone HCl","slug":"trazodone-hcl","phase":"marketed","mechanism":"Trazodone HCl is a serotonin antagonist and reuptake inhibitor (SARI) that blocks serotonin reuptake and antagonizes serotonin 2A receptors to elevate serotonin levels in the brain.","indications":["Major depressive disorder","Insomnia (off-label use, particularly for sleep maintenance)"],"catalyst":""},{"name":"Ultracet®","genericName":"Ultracet®","slug":"ultracet","phase":"marketed","mechanism":"Ultracet combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with acetaminophen to provide enhanced pain relief through dual analgesic pathways.","indications":["Moderate acute pain in adults"],"catalyst":""},{"name":"Zytram","genericName":"Zytram","slug":"zytram","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNYWVIMjFfX2FKVVI2QTdQYnA4ZEhHUmhGZjctYUxmZFpaRjBRTTBrX0JLMlpKaHg1ZmV2U0UwVzJBU1VBM0FQSnphc0VoMVI3eUhZWk5HVnZfNzNiSnZwMVdwODZwUXJ4OFV1RGhSakFSTE9fbl82UGFtZUpTRm0tRlJB?oc=5","date":"2016-06-18","type":"pipeline","source":"SEC.gov","summary":"ex991.htm - SEC.gov","headline":"ex991.htm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNRmNSOGdSOHd1UHhnUzFvV240QjhNa0RHUlFEanppTkVkUFE2aWFuWEMzUlQwbVh0WEphR3FxNkE2Qk1rczhINzBsa1VVQ3JLYXhscWxkNHhGQnFESXNTYm1xd3RDTE9RMDFFdG9oZ0ZwRkZCSTdZdERrcHJLcmdVX1gwRWFIX1ljZVhNWDVuMzVkMURBS1BGS2dLSDQxZWs3OE9UajJmZXhGejFvVXJuM0xLTGh6QWxuWmMyR3F3Y0tUdXpEUUZhbXN2aWdJdw?oc=5","date":"2014-04-18","type":"pipeline","source":"The Globe and Mail","summary":"After brain injury, tenacious CEO builds new drug company - The Globe and Mail","headline":"After brain injury, tenacious CEO builds new drug company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE90aDJKdll2ckFyV1NQa0U4Z0R6NzJvTExRY1M2OTZNUmppemJkNHlBUXhRYzVTcE43YUl0NlJPdGdnM1VQWFpSajliZVBPYjJzVElxQkI2bWdqcC1HRWRWLThoZlhiNkF5ZnBsWFFodjZoVHhLQ2ZUNUphYlk?oc=5","date":"2011-08-18","type":"pipeline","source":"Financial Post","summary":"Paladin Labs CEO in serious accident - Financial Post","headline":"Paladin Labs CEO in serious accident","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQbDB3WGpJSVNWV0FDUUdrOXVYb2VWcGZEaEk3RENnV01Fb0ZocC1heHJsQVBlemZqQXBrV3RMTEJUeS00TUNSZXM5TDRyVjYySV9rX0ZteklpcmlRUEFPMWluenRsbUhSZzhVV1FBa1ZkYkhmcEhlbGp3a01sSDV1blBnWS13TzNqN1NnOTNSLXNPX3c?oc=5","date":"2011-08-17","type":"pipeline","source":"Financial Post","summary":"Paladin takeover rescues ailing Labopharm - Financial Post","headline":"Paladin takeover rescues ailing Labopharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQYVdFNVJCeGVJR2NSU1FqRmpyX3l6X1FPQkEzVDl4cDJqN28xUXltNjdnLU5MLWdfZjU0am56ekhBckxJTFNPZmlCVnlod01fcGJZUEZmOTNEanZVVzU2c1ZXSlhtYUI4WEs4aXRNU2VreGdWYkF6T3dEYVVqV3ZpVXRUR3VkS09vd0ZYYlhNY1NvZzNlWUJGZkF4VEIxSGlBaUlSNVktbkZqbFpHSmZHRw?oc=5","date":"2011-08-17","type":"pipeline","source":"The Globe and Mail","summary":"Onetime star Labopharm scooped up by Paladin Labs - The Globe and Mail","headline":"Onetime star Labopharm scooped up by Paladin Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPbE5uMlZDZldpUlpfdnE1OTBCU3pPNjBrRVNOT2xNMllZeUJvbWduc3JXdFJ1alpsZkxldzlGdzNsTzByQXpIQ2xCQXU0WEc0cHAzcGhCUWk0aUJJTmNTMmRfZTFSRlJIN1kzNG1LUTlURllxMUpWRTlaa2Z2RFRyVVhkelRyWTZ1TWpzdEZ4LWJGam9IdWwtYlJKb3lyRjRoT3p0ejhfbTR3V1czNUVUUi14MmQ?oc=5","date":"2011-01-25","type":"pipeline","source":"RTTNews","summary":"Labopharm Confirms Mary Heino As President, Angelini Labopharm - Quick Facts - RTTNews","headline":"Labopharm Confirms Mary Heino As President, Angelini Labopharm - Quick Facts","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"marketed":4,"phase_3":4,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}